Related Experiment Video
Updated: Aug 17, 2026

Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
Published on: June 2, 2023
Palliative trajectory markers for end-stage heart failure. Or "oh Toto. This doesn't look like kancerous!"
1Hospice Clinical Nurse Specialist, Vancouver Home Hospice Program, Vancouver Coastal Health, Vancouver Home Hospice Team, Vancouver, BC. mark_turris@vrhb.bc.ca
Insights
Identifying palliative care markers for heart failure patients is challenging due to symptom variability. This study reviewed literature and clinical data to find tools for accurately predicting a six-month prognosis for end-stage heart failure.
Area of Science:
- Cardiology
- Palliative Care Medicine
Background:
- Heart failure presents significant morbidity and mortality, with Canadian annual mortality rates ranging from 25% to 40%.
- End-stage heart failure patients experience severe, debilitating symptoms requiring effective palliative care.
- Accurate prognostication for palliative care designation (six months or less) in heart failure is difficult due to unpredictable disease trajectories.
Purpose of the Study:
- To review existing literature for clear palliative trajectory markers in heart failure.
- To assess the feasibility of developing a tool to aid healthcare professionals in identifying patients with a prognosis of six months or less.
Main Methods:
- A comprehensive review of current literature on heart failure palliative care markers.
- Analysis of clinical experience within a major teaching hospital's cardiac clinic in Vancouver.
Main Results:
- The study aimed to identify tangible markers for predicting a six-month or less trajectory in heart failure.
- The research sought to determine if these markers could inform the development of a clinical decision-making tool.
Conclusions:
- Clear palliative trajectory markers for heart failure are needed to improve prognostication.
- A validated tool could significantly assist healthcare professionals in timely palliative care referrals for heart failure patients.
Abstract:
Heart failure is a complex syndrome with a high morbidity and mortality rate. The Canadian mortality rate is between 25% and 40% annually. End-stage heart failure patients suffer from many debilitating symptoms. Palliative symptom management and funding programs can assist many of these patients. Unfortunately, designating a heart failure patient as palliative with a trajectory of six months or less is not an easy task. This is difficult to determine due to the lack of tangible trajectory markers and the roller-coaster nature of the trajectory itself. These circumstances were the impetus for a review of the current literature and a clinical experience in a cardiac clinic within a major teaching hospital in Vancouver. The objective was to determine if clear palliative trajectory markers for heart failure existed and, if so, could they be used to produce a tool to assist health care professionals to accurately determine a timeline of six months or less.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Heart Failure II: Pathophysiology
Heart Failure III: Clinical Manifestations
Pathophysiology of Heart Failure
Heart Failure IV: Classification and Diagnostic Evaluation
